Fabian Hodouschek, Head of Certification at the Federal Office for Information Security (BSI), presents the BSI NESAS certificate to Omar Shahdad, Senior Vice President, Operations at Mavenir BONN, Germany, June 15, 2026 (GLOBE NEWSWIRE) — Mavenir, the software company building Cloud-Native, AI-by-design mobile networks, today announced to be the first tier-1 telecommunications infrastructure software provider […]
MENA
EAACI Calls for a “Vision Zero” Future Free from Allergy and Asthma Burden
Leading allergy experts to convene in Istanbul to explore how science, prevention and policy can reduce the global impact of allergic diseases ZURICH, June 12, 2026 (GLOBE NEWSWIRE) — As allergic diseases continue to affect hundreds of millions of people worldwide and place growing pressure on healthcare systems, the European Academy of Allergy and Clinical […]
Pioneering evidence shows how entrepreneurship model can reduce extreme poverty among refugees
Mary selling goods at the market New studies show DREAMS program boosts incomes, savings, and resilience in refugee communities across East Africa The IKEA Foundation has committed $7.4m to fund the next stage of DREAMS in Ethiopia while the Conrad N. Hilton Foundation has granted $3.5m in funding for the next stage of DREAMS […]
Pioneering evidence shows how entrepreneurship model can reduce extreme poverty among refugees
Mary selling goods at the market New studies show DREAMS program boosts incomes, savings, and resilience in refugee communities across East Africa The IKEA Foundation has committed $7.4m to fund the next stage of DREAMS in Ethiopia while the Conrad N. Hilton Foundation has granted $3.5m in funding for the next stage of DREAMS […]
Kyowa Kirin to Present New Complementary Evidence Further Defining Clinical Utility of Mogamulizumab in Cutaneous T-Cell Lymphoma at 2026 WCCL
New Clinical Data, Patient Reported Outcomes, Real-World Utilization, and Comparative-Effectiveness Models to be Featured in Four Oral and One Poster Presentation PRINCETON, N.J., June 10, 2026 (GLOBE NEWSWIRE) — Kyowa Kirin, Inc., a wholly owned subsidiary of Kyowa Kirin Co. Ltd (TSE: 4151), today announced new data further defining the potential of mogamulizumab in the […]